Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia pacific
1.2.4 Latin America
1.2.5 MEA
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Public sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Pregnancy medication industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Drug class trends
2.1.3 Pregnancy stage trends
2.1.4 Distribution channel trends
2.1.5 Regional trends
Chapter 3 Pregnancy Medication Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing incidence of complications during pregnancy
3.3.1.2 Significant benefits of dietary supplements in pregnancy
3.3.1.3 Rising awareness regarding pregnancy care
3.3.2 Industry pitfalls & challenges
3.3.2.1 Side effects and risks associated with the use of other medication
3.3.2.2 Declining birth rate across the world
3.4 Growth potential analysis
3.4.1 By drug class
3.4.2 By pregnancy stage
3.4.3 by distribution channel
3.5 COVID- 19 impact analysis
3.6 Comparative analysis of nutrition recommendations & daily dietary allowances for pregnant and non-pregnant women
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.8 Porter's analysis
3.8.1 Bargaining power of suppliers
3.8.2 Bargaining power of buyers
3.8.3 Threat of new entrants
3.8.4 Threat of substitutes
3.8.5 Industry rivalry
3.9 PESTLE analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021
Chapter 5 Pregnancy Medication Market, By Drug Class
5.1 Key segment trends
5.2 Antianemia
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Antacids
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Antiallergic
5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Analgesics
5.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.6 Antimicrobials
5.6.1 Market size, by region, 2018 - 2032 (USD Million)
5.7 Hormones
5.7.1 Market size, by region, 2018 - 2032 (USD Million)
5.8 Laxatives
5.8.1 Market size, by region, 2018 - 2032 (USD Million)
5.9 Vaccines
5.9.1 Market size, by region, 2018 - 2032 (USD Million)
5.10 Nutritional supplements
5.10.1 Market size, by region, 2018 - 2032 (USD Million)
5.10.2 Minerals
5.10.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.10.3 Omega 3
5.10.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.10.4 Folic acid
5.10.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.10.5 Vitamins
5.10.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.10.6 Multivitamins
5.10.6.1 Market size, by region, 2018 - 2032 (USD Million)
5.10.7 Others
5.10.7.1 Market size, by region, 2018 - 2032 (USD Million)
5.11 Others
5.11.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Pregnancy Medication Market, By Pregnancy Stage
6.1 Key segment trends
6.2 1st trimester
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 2nd trimester
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 3rd trimester
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Pregnancy Medication Market, By Distribution Channel
7.1 Key segment trends
7.2 Hospital pharmacy
7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Retail pharmacy
7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Online pharmacy
7.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Pregnancy Medication Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2018 - 2032 (USD Million)
8.2.2 Market size, by drug class, 2018 - 2032 (USD Million)
8.2.2.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.2.3 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.2.4 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.2.5 U.S.
8.2.5.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.2.5.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.2.5.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.2.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.2.6 Canada
8.2.6.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.2.6.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.2.6.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.2.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2018 - 2032 (USD Million)
8.3.2 Market size, by drug class, 2018 - 2032 (USD Million)
8.3.2.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.3.3 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.3.4 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.3.5 Germany
8.3.5.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.3.5.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.3.5.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.3.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.3.6 UK
8.3.6.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.3.6.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.3.6.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.3.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.3.7 France
8.3.7.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.3.7.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.3.7.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.3.7.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.3.8 Italy
8.3.8.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.3.8.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.3.8.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.3.8.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.3.9.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.3.9.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.3.9.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2018 - 2032 (USD Million)
8.4.2 Market size, by drug class, 2018 - 2032 (USD Million)
8.4.2.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.4.3 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.4.4 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.4.5 China
8.4.5.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.4.5.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.4.5.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.4.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.4.6 Japan
8.4.6.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.4.6.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.4.6.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.4.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.4.7 India
8.4.7.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.4.7.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.4.7.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.4.7.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.4.8 Australia
8.4.8.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.4.8.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.4.8.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.4.8.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.4.9 South Korea
8.4.9.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.4.9.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.4.9.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.4.9.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2018 - 2032 (USD Million)
8.5.2 Market size, by drug class, 2018 - 2032 (USD Million)
8.5.2.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.5.3 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.5.4 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.5.5 Brazil
8.5.5.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.5.5.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.5.5.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.5.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.5.6 Mexico
8.5.6.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.5.6.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.5.6.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.5.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.5.7 Argentina
8.5.7.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.5.7.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.5.7.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.5.7.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.6 Middle East & Africa
8.6.1 Market size, by country, 2018 - 2032 (USD Million)
8.6.2 Market size, by drug class, 2018 - 2032 (USD Million)
8.6.2.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.6.3 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.6.4 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.6.5 South Africa
8.6.5.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.6.5.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.6.5.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.6.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.6.6 Saudi Arabia
8.6.6.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.6.6.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.6.6.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.6.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
8.6.7 UAE
8.6.7.1 Market size, by drug class, 2018 - 2032 (USD Million)
8.6.7.1.1 Market size, by nutritional supplements, 2018 - 2032 (USD Million)
8.6.7.2 Market size, by pregnancy stage, 2018 - 2032 (USD Million)
8.6.7.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
Chapter 9 Company Profiles
9.1 F. Hoffmann-La Roche Ltd
9.1.1 Business overview
9.1.2 Financial data
9.1.3 Product landscape
9.1.4 Strategic outlook
9.1.5 SWOT analysis
9.2 Alkem Laboratories Limited
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Piramal Enterprises Limited
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Cipla Limited
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Pfizer Inc
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 Dr. Reddy’s Laboratories
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 Alembic Pharmaceuticals Ltd
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 Lupin Limited
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Glenmark Pharmaceuticals Ltd
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Viatris Inc. (Mylan Inc.)
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Amgen Inc
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
